|Clinical Assistant Professor|
Jessica Joines is the Director of the Master’s in Genetic Counseling Program (MGCP), a track of the Microbiology and Molecular Genetics Program. Ms. Joines obtained a Bachelor’s of Science from the University of Richmond and a Master’s in Genetic Counseling from the University of Maryland, Baltimore She is certified by the American Board of Genetic Counseling. Ms. Joines has worked in a variety of clinical genetics settings including cancer, pediatrics, and neurology. She has over fifteen years of experience of working with families who may carry an inherited susceptibility to cancer. Her interests include cancer genetic counseling and genetic counseling professional development.
In her role of Director of the MGCP she will oversee the administration, curriculum, and clinical placements of the graduate genetic counseling students. The MGCP aims to accept its first class of students in Fall 2017.
Kaufman E, Peshkin B, Lawrence W, Shelby R, Isaacs C, Brown K, Rispoli J, O’Neill S, Hurley K, DeMarco T, Brogan B, Grumet S, Jandorf L, McKenna K, Valdimarsdottir H, Schwartz M. Development of an Interactive Decision Aid for Female BRCA1/BRCA2 Carriers. Journal of Gen Counseling 2003; 12: 109-129.
O'Neill, S. C., DeMarco, T., Peshkin, B. N., Rogers, S., Rispoli, J.,Brown, K., Valdimarsdottir, H., & Schwartz, M. D. (2006). Tolerance for uncertainty, perceived risk and distress among women receiving uninformative BRCA1/BRCA2 results. American Journal of Medical Genetics, 142C, 251-259.
O'Neill, S. C., Kaufman, E., DeMarco, T., Peshkin, B. N., McKenna, K., Shelby, R., Valdimarsdottir, H., Rispoli, J., & Schwartz, M. D. Changes in diet and physical activity following BRCA1/2 testing. Journal of Psychosocial Oncology 2008; 26(3):63-80.
Schwartz, M., Valdimarsdottir, H., DeMarco, T., Peshkin, B., Lawrence, W., Rispoli, J., Brown, K., Isaacs, C., O’Neill, S., Shelby, R., Grumet, S., McGovern, M., Garnett, S., Bremer, H., Leaman, S., O’Mara, K., Kelleher, S., Komaridis, K. Randomized trial of a decision aid for BRCA1/BRCA2 mutation carriers: Impact on measures of decision making and satisfaction. Health Psychology 2009; 28(1):11.